Ixekizumab therapy following secukinumab inadequate response in psoriatic arthritis: a case series focusing on axial disease.

MLA

Panagiotopoulos, Alexandros, et al. “Ixekizumab Therapy Following Secukinumab Inadequate Response in Psoriatic Arthritis: A Case Series Focusing on Axial Disease.” Rheumatology International, vol. 43, no. 5, May 2023, pp. 969–73. EBSCOhost, https://doi.org/10.1007/s00296-023-05289-3.

APA

Panagiotopoulos, A., Koutsianas, C., Kougkas, N., Moschou, D., Bournia, V.-K., Gazi, S., Tektonidou, M. G., Vassilopoulos, D., Sfikakis, P. P., & Fragoulis, G. E. (2023). Ixekizumab therapy following secukinumab inadequate response in psoriatic arthritis: a case series focusing on axial disease. Rheumatology International, 43(5), 969–973. https://doi.org/10.1007/s00296-023-05289-3

Chicago

Panagiotopoulos, Alexandros, Christos Koutsianas, Nikolaos Kougkas, Dimitra Moschou, Vasiliki-Kalliopi Bournia, Sousana Gazi, Maria G. Tektonidou, Dimitrios Vassilopoulos, Petros P. Sfikakis, and George E. Fragoulis. 2023. “Ixekizumab Therapy Following Secukinumab Inadequate Response in Psoriatic Arthritis: A Case Series Focusing on Axial Disease.” Rheumatology International 43 (5): 969–73. doi:10.1007/s00296-023-05289-3.